[
  {
    "ts": null,
    "headline": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=54643a3479ebf012f374d5c3d9011cfd7c69cd746d213ac097c155525028d08e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759499402,
      "headline": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
      "id": 136981119,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=54643a3479ebf012f374d5c3d9011cfd7c69cd746d213ac097c155525028d08e"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Health Care Stocks Bet ACA Deal Will End Government Shutdown",
    "summary": "S&P 500 Health Care Stocks Bet ACA Deal Will End Government Shutdown",
    "url": "https://finnhub.io/api/news?id=e1ed8264f87cecbe867959fc4e40a8c60ea1e02da2b4c7847265000851d37e42",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759497593,
      "headline": "S&P 500 Health Care Stocks Bet ACA Deal Will End Government Shutdown",
      "id": 136995978,
      "image": "",
      "related": "HCA",
      "source": "DowJones",
      "summary": "S&P 500 Health Care Stocks Bet ACA Deal Will End Government Shutdown",
      "url": "https://finnhub.io/api/news?id=e1ed8264f87cecbe867959fc4e40a8c60ea1e02da2b4c7847265000851d37e42"
    }
  },
  {
    "ts": null,
    "headline": "Top 50 High-Quality Dividend Growth Stocks For October 2025",
    "summary": "A list of top dividend growth stocks for 2025 with strong return potential is provided. See which undervalued picks offer the best blend of yield and growth.",
    "url": "https://finnhub.io/api/news?id=9c78efb85c861b39623e6f935effc4add6f3514e693a00435ac22aafd8745797",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759488387,
      "headline": "Top 50 High-Quality Dividend Growth Stocks For October 2025",
      "id": 136964924,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2224990654/image_2224990654.jpg?io=getty-c-w1536",
      "related": "HCA",
      "source": "SeekingAlpha",
      "summary": "A list of top dividend growth stocks for 2025 with strong return potential is provided. See which undervalued picks offer the best blend of yield and growth.",
      "url": "https://finnhub.io/api/news?id=9c78efb85c861b39623e6f935effc4add6f3514e693a00435ac22aafd8745797"
    }
  },
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Reiterates a Buy Rating on HCA Healthcare (HCA) With a $444 PT",
    "summary": "HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical stocks to buy now. In a report released on September 26, Sarah James from Cantor Fitzgerald reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) and set a price target of $444.00. HCA Healthcare, Inc. (NYSE:HCA) reported a 6.4% growth in its revenues for fiscal […]",
    "url": "https://finnhub.io/api/news?id=41ff86bef40ee59ec5f47c506b767a042b2c27091809c7d238c5b305aa58ce8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759487278,
      "headline": "Cantor Fitzgerald Reiterates a Buy Rating on HCA Healthcare (HCA) With a $444 PT",
      "id": 136963290,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical stocks to buy now. In a report released on September 26, Sarah James from Cantor Fitzgerald reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) and set a price target of $444.00. HCA Healthcare, Inc. (NYSE:HCA) reported a 6.4% growth in its revenues for fiscal […]",
      "url": "https://finnhub.io/api/news?id=41ff86bef40ee59ec5f47c506b767a042b2c27091809c7d238c5b305aa58ce8d"
    }
  }
]